Attenuated Salmonella typhimurium carrying TRAIL and VP3 genes inhibits the growth of gastric cancer cells in vitro and in vivo

Tumori

Volumn 96, Issue 2, 2010, Pages 296-303

  Cao, Hong Dan ^a   Yang, Yin Xue ^b   Lü, Lin ^a   Liu, Shao Ning ^a   Wang, Pi Long ^a   Tao, Xiao Hong ^a   Wang, Li Juan ^a   Xiang, Ting Xiu ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Attenuated Salmonella typhimurium; Gastric cancer; TRAIL; VP3

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; APOPTIN; CASPASE 3; CASPASE 9; PLASMID VECTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER REGRESSION; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOUSE; NICK END LABELING; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PROTEIN EXPRESSION; PROTEIN INDUCTION; SALMONELLA TYPHIMURIUM; STOMACH CANCER; WESTERN BLOTTING;

EID: 77952908442     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600218     Document Type: Article

References (27)

1. Gura T: How TRAIL kills cancer cells, but not normal cells. Science, 277: 768-771, 1997.
2. Naka T, Sugamura K, Hylander BL, Widmer MB, Rustum YM, Repasky EA: Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res, 62: 5800-5806, 2002. (Pubitemid 35204738)
3. Zhuang SM, Landegent JE, Verschueren CA, Falkenburg JH, van Ormondt H, van der Eb AJ, Noteborn MH: Apoptin, a protein encoded by chicken anemia virus, induces cell death in various human hematologic malignant cells in vitro. Leukemia, 9 (suppl 1): 118-120, 1995.
4. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG: Identification and characterization of a new member of the TNF family. Immunity, 3: 673-682, 1995.
5. Danen-Van Oorschot AA, Fischer DF, Grimbergen JM, Klein B, Zhuang S, Falkenburg JH, Backendorf C, Quax PH, Van der Eb AJ, Noteborn MH: Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells. Proc Natl Acad Sci USA, 94: 5843-5847, 1997. (Pubitemid 27241859)
6. Zhuang SM, Shvarts A, Jochemsen AG, van Oorschot AA, van der Eb AJ, Noteborn MH: Differential sensitiveity to Ad5 E1B-21kD and Bcl-2 proteins of apoptin-induced versus p53-induced apoptosis. Carcinogenesis, 16: 2939-2944, 1995. (Pubitemid 26004603)
7. Grillot-Courvalin C, Goussard S, Courvalin P: Bacteria as gene delivery vectors for mammalian cells. Curr Opin Biotechnol, 10: 477-481, 1999. (Pubitemid 29457274)
8. Grillot-Courvalin C, Goussard S, Courvalin P: Wild-type intracellular bacteria deliver DNA intomammalian cells. Cell Microbiol, 4: 177-186, 2002. (Pubitemid 34257734)
9. Darji A, Lage S, Garbe AI, Chakraborty T, Weiss S: Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol, 27: 341-349, 2000.
10. Reisfeld RA, Niethammer AG, Luo Y, Xiang R: DNA vaccines suppress tumor growth andmetastases by the induction of antiangiogenesis. Immunol Rev, 199: 181-190, 2004. (Pubitemid 38736771)
11. Agorio C, Schreiber F, Sheppard M, Mastroeni P, Fernandez M, Martinez MA, Chabalgoity JA: Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. J Gene Med, 9: 416-423, 2007.
12. Chatfield S, Roberts M, Li J, Starns A, Dougan G: The use of live attenuated Salmonella for oral vaccination. Dev Biol Stand, 82: 35-42, 1994.
13. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science, 267: 1456-1462, 1985.
14. Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM: Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Int J Cancer, 99: 491-504, 2002. (Pubitemid 34461601)
15. Papageorgiou A, Lashinger L, Millikan R, Grossman HB, Benedict W, Dinney CP, McConkey DJ: Role of tumor necrosis factor-related apoptosis-inducing ligand in interferon-induced apoptosis in human bladder cancer cells. Cancer Res, 64: 8973-8979, 2004. (Pubitemid 39665506)
16. Maddika S, Booy EP, Johar D, Gibson SB, Ghavami S, Los M: Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway. J Cell Sci, 118: 4485-4493, 2005. (Pubitemid 41556346)
17. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell, 94: 491-501, 1998. (Pubitemid 28391865)
18. Harper N, Farrow SN Kaptein A, Cohen GM, Macfarlane M: Modulation of tumor necrosis factor apoptosis-inducing ligand-induced NF-kappa B activation by inhibition of apical caspases. J Biol Chem, 276: 34743-34752, 2001. (Pubitemid 37384473)
19. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA: Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med, 186: 1165-1170, 1997. (Pubitemid 27441160)
20. Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M: Lipid A mutant Salmonella with suppressed virulence and TNFa induction retain tumor-targeting in vivo. Nat Biotechnol, 17: 37-41, 1999.
21. Jain RK, Forbes NS: Can engineered bacteria help control cancer? Proc Natl Acad Sci USA, 98: 14748-14750, 2001.
22. Loeffler M, Le'Negrate G, Krajewska M, Reed JC: Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. PNAS, 104: 12879-12883, 2007.
23. Zhao M, Geller J, Ma HY, Yang M, Penman S, Hoffman RM: Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer. Proc Natl Acad Sci U S A, 104: 10170-10174, 2007.
24. Paglia BP, Medina E, Arioli I, Guzman CA, Colombo MP: Transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium results in protective immunity against a murine fibrosarcoma. Blood, 92: 3172-3176, 1998.
25. Schafer R, Nacy CA, Eisenstein TK: Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella. J Immunol, 140: 1638-1644, 1988.
26. Meng FP, Ding J, Yu ZC, Han QL, Guo CC, Liu N, Fan DM: Oral attenuated Salmonella typhimurium vaccine against MG7-Ag mimotope of gastric cancer. World J Gastroenterol, 11: 1833-1836, 2005.
27. Darji A, Guzman CA, Gerstel B, Wachholz P, Timmis KN, Wehland J, Chakraborty T, Weiss S. Oral somatic transgene vaccination using attenuated S. typhymurium. Cell, 91: 765-775, 1997. (Pubitemid 28007733)